Physician profile
Gemma Patel
NPI 1740613876
$3,638.71
in general payments reported to CMS, 2019-2025
13 companies · $847 in 2025
The $847 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $156 · 2021: $229 · 2022: $864 · 2023: $431 · 2024: $913 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044 · Entertainment: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.14 |
| Entertainment | $146.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,826.26 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $724.11 | 2019-2025 | |
| Alcon Vision LLC | $427.50 | 2019-2025 | Dailies Total1, Precision 1, Precision7 |
| Optos, INC. | $146.77 | 2024-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $109.65 | 2022 | |
| Sun Pharmaceutical Industries INC. | $102.65 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $83.93 | 2023-2025 | Infuse, Miebo, Xiidra |
| Abb Con-Cise Optical Group LLC | $57.41 | 2020-2025 | Spectacle Lenses, Contact Lens |
| Harrow Eye, LLC | $55.85 | 2025 | Vevye |
| Lombart Brothers, INC. | $49.19 | 2020-2022 | |
| Carl Zeiss Meditec USA, INC. | $19.56 | 2025 | Humphrey Hfa |
| Shire North American Group INC | $18.43 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gemma Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.